Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Industri Jamu dan Farmasi Sido Muncul Tbk PT
Other
Industri Jamu dan Farmasi Sido Muncul Tbk PT
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Victoria Care Indonesia Tbk PT
IDX:VICI
|
Other
-Rp7.7B
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mustika Ratu Tbk PT
IDX:MRAT
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kino Indonesia Tbk PT
IDX:KINO
|
Other
-Rp129.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Mandom Indonesia Tbk PT
IDX:TCID
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Ikapharmindo Putramas Tbk PT
IDX:IKPM
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
Glance View
Industri Jamu dan Farmasi Sido Muncul Tbk PT, a name synonymous with traditional Indonesian herbal remedies, represents a blend of age-old wisdom and modern business acumen. Founded in 1940, the company originally started as a small herbal medicine business, peddling concoctions crafted from local plants and herbs. Over the decades, it transformed into a leading player in the Indonesian pharmaceutical industry through its commitment to nurturing folk medicine heritage and melding it with contemporary manufacturing processes. Today's Sido Muncul operates sophisticated production facilities that comply with stringent safety and quality standards, embodying the rich tradition of jamu – Indonesia’s indigenous elixir – while ensuring products meet the demands of modern efficacy and safety. The company earns its revenue from an extensive array of products, primarily categorized into herbal medicines, supplements, and health drinks. Notably, an innovative approach lies at the core of its earnings strategy: leveraging the health benefits of jamu to cater to an increasingly health-conscious population. With a prolific distribution network, Sido Muncul ensures its products reach both local and international markets, spanning across Asia, the Middle East, and beyond. Their diverse range of offerings, from energy-bolstering drinks to ailment-specific concoctions, reinforces its financial robustness, serving a wide clientele that values both health and tradition. The firm’s continuous investment in research and development helps it stay ahead in the competitive herbal market, steadily propelling its growth and fortifying its role as a custodian of Indonesian cultural heritage in the global arena.